SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-20-014570
Filing Date
2020-03-31
Accepted
2020-03-31 17:00:37
Documents
6
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A crsp-pre14a_20200611.htm PRE 14A 2405009
2 GRAPHIC gqzb2byjm5ly000001.jpg GRAPHIC 4427
3 GRAPHIC gqzb2byjm5ly000004.jpg GRAPHIC 67357
4 GRAPHIC gqzb2byjm5ly000003.jpg GRAPHIC 78835
5 GRAPHIC gqzb2byjm5ly000005.jpg GRAPHIC 23043
6 GRAPHIC gqzb2byjm5ly000002.jpg GRAPHIC 3053
  Complete submission text file 0001564590-20-014570.txt   2650055
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37923 | Film No.: 20762569
SIC: 2836 Biological Products, (No Diagnostic Substances)